- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04294927
TUBectomy med forsinket Oophorectomy hos høyrisikokvinner for å vurdere sikkerheten ved forebygging (TUBA-WISP-II)
TUBectomy med forsinket Oophorectomy som alternativ for risikoreduserende Salpingo-ooforektomi hos høyrisikokvinner for å vurdere sikkerheten ved forebygging: TUBA-WISP II-studie.
The aim of the project is to evaluate the risk-reducing salpingectomy with delayed oophorectomy as an alternative for risk-reducing salpingo-oophorectomy in high risk women with respect to ovarian cancer incidence.
Studieoversikt
Status
Forhold
Detaljert beskrivelse
In BRCA1/2 gene mutation carriers, a risk-reducing salpingo-oophorectomy (RRSO) is recommended around the age of 40. This recommendation is based on a 10-40% life-time risk of ovarian cancer in this population and disappointing results of ovarian cancer surveillance for early detection. Moreover, the mortality rate of ovarian cancer is high. Effects of RRSO are a decrease in ovarian cancer risk (80-96%) on one hand and immediate onset of menopause and non-cancer related morbidity on the other hand. The fifty percent breast cancer risk reduction after RRSO has become disputable in the last years. Based on multiple studies showing that most high-grade serous ovarian cancers develop at the distal end of the Fallopian tube, an innovative strategy for RRSO has been developed for this study proposal: risk-reducing salpingectomy (RRS) with delayed risk-reducing oophorectomy (RRO). However, the safety of this strategy has not been proven yet. Before implementing this innovative strategy as standard care we need to investigate the long term effects on ovarian cancer incidence.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Joanne A. de Hullu, MD, PhD
- Telefonnummer: +31 (0) 24 36 16683
- E-post: Joanne.deHullu@radboudumc.nl
Studer Kontakt Backup
- Navn: Karen H. Lu, MD, PhD
- Telefonnummer: (713) 745-8902
- E-post: khlu@mdanderson.org
Studiesteder
-
-
-
Brisbane, Australia
- Rekruttering
- The Mater Hospital
-
Ta kontakt med:
- Ngaire Latch
- Telefonnummer: +61394266666
- E-post: ngaire.latch@unimelb.edu.au
-
Melbourne, Australia
- Rekruttering
- Monash Health
-
Ta kontakt med:
- Martha Hickey
-
Melbourne, Australia
- Rekruttering
- Peter MacCallum Centre
-
Ta kontakt med:
- Martha Hickey
-
Melbourne, Australia
- Rekruttering
- Royal Womens Hospital
-
Ta kontakt med:
- Martha Hickey
-
-
New South Wales
-
Sydney, New South Wales, Australia, 2050
- Rekruttering
- Chris O'Brien Lifehouse
-
Ta kontakt med:
- Ngaire Latch
- Telefonnummer: +61285140000
- E-post: ngaire.latch@unimelb.edu.au
-
Sydney, New South Wales, Australia, 2145
- Rekruttering
- Westmead hospital
-
Ta kontakt med:
- Ngaire Latch
- Telefonnummer: +61288905555
- E-post: ngaire.latch@unimelb.edu.au
-
-
Queensland
-
Brisbane, Queensland, Australia, 4001
- Rekruttering
- St Andrew War Memorial Hospital
-
Ta kontakt med:
- Ngaire Latch
- Telefonnummer: +61738344444
- E-post: ngaire.latch@unimelb.edu.au
-
Brisbane, Queensland, Australia, 4006
- Rekruttering
- Royal Brisbane Hospital
-
Ta kontakt med:
- Ngaire Latch
- Telefonnummer: +61736468111
- E-post: ngaire.latch@unimelb.edu.au
-
Brisbane, Queensland, Australia, 4120
- Rekruttering
- Greenslopes Private Hospital
-
Ta kontakt med:
- Ngaire Latch
- Telefonnummer: +61733947111
- E-post: ngaire.latch@unimelb.edu.au
-
-
South Australia
-
Adelaide, South Australia, Australia, 5000
- Rekruttering
- Royal Adelaide Hospital
-
Ta kontakt med:
- Ngaire Latch
- Telefonnummer: +61870740000
- E-post: ngaire.latch@unimelb.edu.au
-
-
Victoria
-
Melbourne, Victoria, Australia, 3050
- Rekruttering
- Frances Perry House
-
Ta kontakt med:
- Ngaire Latch
- Telefonnummer: +61393445000
- E-post: ngaire.latch@unimelb.edu.au
-
Melbourne, Victoria, Australia, 3084
- Rekruttering
- Mercy Hospital
-
Ta kontakt med:
- Ngaire Latch
- Telefonnummer: +61 3 8458 4444
- E-post: ngaire.latch@unimelb.edu.au
-
Richmond, Victoria, Australia, 3121
- Rekruttering
- Epworth Hospital
-
Ta kontakt med:
- Ngaire Latch
- Telefonnummer: +61394266666
- E-post: ngaire.latch@unimelb.edu.au
-
St Albans, Victoria, Australia, 3021
- Rekruttering
- Western Health
-
Ta kontakt med:
- Ngaire Latch
- Telefonnummer: 03 8345 1333
- E-post: ngaire.latch@unimelb.edu.au
-
-
Western Australia
-
Perth, Western Australia, Australia, 6008
- Rekruttering
- King Edward Memorial Hospital
-
Ta kontakt med:
- Ngaire Latch
- Telefonnummer: +61864582222
- E-post: ngaire.latch@unimelb.edu.au
-
-
-
-
-
Brussels, Belgia
- Rekruttering
- Hopital Universitaire Bruxelles
-
Ta kontakt med:
- Maxime Fastrez
-
Leuven, Belgia
- Rekruttering
- Universitair Ziekenhuis Leuven
-
Ta kontakt med:
- Susanne Housmans
-
-
-
-
-
São Paulo, Brasil
- Rekruttering
- AC Camargo Cancer Centre
-
Ta kontakt med:
- Glauco Baiocchi
-
-
-
-
-
Vancouver, Canada
- Rekruttering
- Vancouver General Hospital
-
Ta kontakt med:
- Janice Kwon
-
-
-
-
Illinois
-
Chicago, Illinois, Forente stater, 60637
- Rekruttering
- UChicago Medicine
-
Ta kontakt med:
- Kathryn Mills
-
-
Massachusetts
-
Boston, Massachusetts, Forente stater, 02215
- Rekruttering
- Dana Farber Cancer Institute
-
Ta kontakt med:
- Karen Lu
-
-
Minnesota
-
Rochester, Minnesota, Forente stater, 55905
- Rekruttering
- Mayo Clinic
-
Ta kontakt med:
- Karen Lu
-
-
Missouri
-
St Louis, Missouri, Forente stater, 63110
- Rekruttering
- Washington University Medical Center
-
Ta kontakt med:
- Andrea Hagemann
-
-
New York
-
New York, New York, Forente stater, 10065
- Rekruttering
- Memorial Sloan Kettering Cancer Center
-
Ta kontakt med:
- Kara Long Roche
-
New York, New York, Forente stater, 10029
- Rekruttering
- Mount Sinai Hospital
-
Ta kontakt med:
- Stephanie Blank
-
-
North Carolina
-
Durham, North Carolina, Forente stater, 27705
- Rekruttering
- Duke University Hospital
-
Ta kontakt med:
- Haley Moss
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forente stater, 19104
- Rekruttering
- Hospital of the University of Pennsylvania
-
Ta kontakt med:
- Sarah Kim
-
-
Texas
-
Houston, Texas, Forente stater, 77030-4009
- Rekruttering
- MD Anderson Cancer Centre
-
Ta kontakt med:
- Karen Lu
-
Houston, Texas, Forente stater, 77026
- Rekruttering
- Harris Health Lyndon B. Johnson Hospital
-
Ta kontakt med:
- Michaela Onstad-Grinsfelder
-
-
Washington
-
Seattle, Washington, Forente stater, 98195
- Rekruttering
- University of Washington
-
Ta kontakt med:
- Elizabeth Swisher
-
-
-
-
-
Cork, Irland
- Rekruttering
- Cork University Hospital
-
Ta kontakt med:
- Zibi Marchoki
-
-
-
-
-
Bologna, Italia
- Rekruttering
- Universita di Bologna
-
Ta kontakt med:
- Myriam Perrone
-
Milan, Italia
- Rekruttering
- Humanitas San Pio X
-
Ta kontakt med:
- Fabio Martinelli
-
Monza, Italia
- Rekruttering
- San Gerardo Hospital
-
Ta kontakt med:
- Robert Fruscio
-
Rome, Italia
- Rekruttering
- Gemelli Hospital
-
Ta kontakt med:
- Claudia Marchetti
-
-
-
-
-
Mexico City, Mexico
- Rekruttering
- Instituto Nacional de Cancerología
-
Ta kontakt med:
- David Cantu
-
-
-
-
-
Amsterdam, Nederland
- Rekruttering
- Antoni van Leeuwenhoek
-
Ta kontakt med:
- Teska Schuurman, MD, PhD
-
Amsterdam, Nederland
- Rekruttering
- Amsterdam University Medical Center
-
Ta kontakt med:
- Luc van Lonkhuijzen, MD, PhD
-
Breda, Nederland
- Rekruttering
- Amphia
-
Ta kontakt med:
- Janneke Hoogstad, MD, PhD
-
Enschede, Nederland
- Rekruttering
- Medisch Spectrum Twente
-
Ta kontakt med:
- Nathalie Reesink-Peters, MD, PhD
-
Groningen, Nederland
- Rekruttering
- University Medical Center Groningen
-
Ta kontakt med:
- Marise Wagener, MD, PhD
-
Leeuwarden, Nederland
- Rekruttering
- Medical Center Leeuwarden
-
Ta kontakt med:
- Mirjam Apperloo, MD, PhD
-
Leiden, Nederland
- Rekruttering
- Leiden University Medical Center
-
Ta kontakt med:
- Katja Gaarenstroom, MD, PhD
-
Rotterdam, Nederland
- Rekruttering
- Erasmus Medical Center
-
Ta kontakt med:
- Eva Roes, MD, PhD
-
Utrecht, Nederland
- Rekruttering
- University Medical Center Utrecht
-
Ta kontakt med:
- Ronald Zweemer, Prof, MD, PhD
-
Veldhoven, Nederland
- Rekruttering
- Maxima Medical Center
-
Ta kontakt med:
- Sjors Coppus, MD, PhD
-
Zwolle, Nederland
- Rekruttering
- Isala Klinieken
-
Ta kontakt med:
- Arnold-Jan Kruse, MD, PhD
-
-
Gelderland
-
Nijmegen, Gelderland, Nederland
- Rekruttering
- Radboudumc
-
Ta kontakt med:
- Joanne A. de Hullu, MD, PhD
- Telefonnummer: +31 (0) 24 36 16683
- E-post: Joanne.deHullu@radboudumc.nl
-
-
Limburg
-
Maastricht, Limburg, Nederland
- Rekruttering
- Maastricht University Medical Center
-
Ta kontakt med:
- Brigitte Slangen, MD, PhD
-
-
North Brabant
-
Eindhoven, North Brabant, Nederland, 5623 EJ
- Rekruttering
- Catharina Ziekenhuis
-
Ta kontakt med:
- Jurgen M.J. Piek, MD, PhD
- E-post: jurgen.piek@catharinaziekenhuis.nl
-
Tilburg, North Brabant, Nederland
- Rekruttering
- Elisabeth-TweeSteden Ziekenhuis
-
Ta kontakt med:
- Caroline Vos, MD
-
-
-
-
-
Nordbyhagen, Norge
- Aktiv, ikke rekrutterende
- Akershus University Hospital
-
Oslo, Norge
- Rekruttering
- Oslo University Hospital
-
Ta kontakt med:
- Anne Dorum
-
Stavanger, Norge
- Rekruttering
- Stavanger Uniersity Hospital
-
Ta kontakt med:
- Anne Dorum
-
-
-
-
-
Gdynia, Polen
- Rekruttering
- Gdynia Oncology Centre
-
Ta kontakt med:
- Maciej Stukan
-
Katowice, Polen
- Rekruttering
- Medical University of Silesia
-
Ta kontakt med:
- Krzysztof Nowosielski
-
Katowice, Polen
- Rekruttering
- Bonifraterskie Centrum Medyczne
-
Ta kontakt med:
- Monika Bodjys-Szyndlar
-
Warsaw, Polen
- Rekruttering
- National Cancer Institute Warsaw
-
Ta kontakt med:
- Agnieszka Rychlik
-
-
-
-
-
Barcelona, Spania
- Rekruttering
- Vall D'Hebron Barcelona
-
Ta kontakt med:
- Judith Balmana
-
-
-
-
-
Stockholm, Sverige
- Rekruttering
- Karolinksa Institutet
-
Ta kontakt med:
- Angelique Flöter-Radestad
-
-
-
-
-
Amberg, Tyskland
- Rekruttering
- Klinikum St. Marien Amberg
-
Ta kontakt med:
- Thomas Papathemelis
-
Bad Homburg, Tyskland
- Rekruttering
- Hochtaunus-Kliniken Bad Homburg
-
Ta kontakt med:
- Dominik Denschlag
-
Berlin-Spandau, Tyskland
- Rekruttering
- Evangelische Waldkrankenhaus Spandau Berlin
-
Ta kontakt med:
- Katharina Carrizo
-
Detmold, Tyskland
- Rekruttering
- Klinikum Lippe Detmold
-
Ta kontakt med:
- Beyhan Ataseven
-
Dresden, Tyskland
- Rekruttering
- Universitätsklinikum Carl Gustav Carus Dresden an der Technischen Universität Dresden
-
Ta kontakt med:
- Pauline Wimberger
-
Düsseldorf, Tyskland
- Rekruttering
- Universitätsklinikum Düsseldorf
-
Ta kontakt med:
- Tanja Fehm
-
Düsseldorf, Tyskland
- Rekruttering
- Florence-Nightingale-Krankenhaus Düsseldorf
-
Ta kontakt med:
- Saher Baransi
-
Essen, Tyskland
- Rekruttering
- Evang. Kliniken Essen-Mitte
-
Ta kontakt med:
- Philipp Harter
-
Hamburg, Tyskland
- Rekruttering
- Universitätsklinikum Hamburg-Eppendorf
-
Ta kontakt med:
- Barbara Schmalfeld
-
Hamburg, Tyskland
- Rekruttering
- Mammazentrum Hamburg am Krankenhaus Jerusalem
-
Ta kontakt med:
- Felix Hilpert
-
Hanover, Tyskland
- Rekruttering
- Medizinische Hochschule Hannover
-
Ta kontakt med:
- Elna Kühnle
-
Heidelberg, Tyskland
- Rekruttering
- Medizinische Fakultät Mannheim der Universität Heidelberg
-
Ta kontakt med:
- Frederik Marmé
-
Heidelberg, Tyskland
- Rekruttering
- Universitäts-Frauenklinik Heidelberg
-
Ta kontakt med:
- Oliver Zivanovic
-
Mainz, Tyskland
- Rekruttering
- Universitätsmedizin Mainz
-
Ta kontakt med:
- Anette Hasenburg
-
München, Tyskland
- Rekruttering
- Rotkreuzklinikum München
-
Ta kontakt med:
- Martin Pölcher
-
München, Tyskland
- Rekruttering
- Klinikum rechts an der Isar Technische Universität München
-
Ta kontakt med:
- Holger Bronger
-
Münster, Tyskland
- Rekruttering
- Universitätsklinikum Münster
-
Ta kontakt med:
- Carl Christian Opitz
-
-
-
-
-
Montevideo, Uruguay
- Rekruttering
- Hospital Británico
-
Ta kontakt med:
- Santiago Scasso
-
-
-
-
-
Graz, Østerrike
- Rekruttering
- Medical University of Graz
-
Ta kontakt med:
- Karl Tamussino
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
-
Women with a class 5 (definitely pathogenic) BRCA1, BRCA2, RAD51C, RAD51D, BRIP1 or PALB2 germline mutation in one of the participating centers.
-
Age at inclusion;
- BRCA1: 25-40 years
- BRCA2: 25-45 years
- RAD51C, RAD51D, BRIP1 & PALB2: 25-50 years
-
Childbearing completed
-
Presence of at least one fallopian tube
-
Participants may have a personal history of non-ovarian malignancy
-
Informed consent must be obtained and documented according to national and local regulatory requirements and the local rules followed in the institution.
Exclusion Criteria:
- Postmenopausal status (natural menopause or due to treatment)
- Wish for second stage RRO within two years after RRS
- Legally incapable
- Prior bilateral salpingectomy
- A personal history of ovarian, fallopian tube or peritoneal cancer
- Current diagnosis or treatment for malignant disease
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Ikke-randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Risk-reducing salpingectomy with delayed oophorectomy
Risk-reducing salpingectomy after the completion of childbearing with delayed oophorectomy. |
|
|
Aktiv komparator: Risk-reducing salpingo-oophorectomy
Risk-reducing salpingo-oophorectomy. |
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
High grade serous (ovarian) cancer incidence
Tidsramme: Until the age of 45 for BRCA1 and 50 for BRCA2 germline mutation carriers
|
High grade serous (ovarian) cancer incidence |
Until the age of 45 for BRCA1 and 50 for BRCA2 germline mutation carriers
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Incidence of (pre)malignant findings in tubes/ovaries
Tidsramme: 6 weeks after each surgery
|
Incidence of (pre)malignant findings in tubes/ovaries at risk-reducing salpingectomy, oophorectomy and salpingo-oophorectomy. |
6 weeks after each surgery
|
|
Peri-operative morbidity and mortality
Tidsramme: 6 weeks after each surgery
|
Peri-operative morbidity and mortality |
6 weeks after each surgery
|
|
Incidence of pelvic cancer (other than ovarian cancer)
Tidsramme: Up to the age of 70
|
Incidence of pelvic cancer (other than ovarian cancer) |
Up to the age of 70
|
|
Incidence of breast cancer
Tidsramme: Up to the age of 70
|
Incidence of breast cancer |
Up to the age of 70
|
|
Uptake of risk reducing oophorectomy
Tidsramme: Up to the age of 70
|
Uptake of risk reducing oophorectomy after risk reducing salpingectomy |
Up to the age of 70
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
High grade serous (ovarian) cancer incidence at the age of 70
Tidsramme: Up to the age of 70
|
Exploratory outcome measure |
Up to the age of 70
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Joanne A. de Hullu, MD, PhD, Radboud University Medical Center
- Hovedetterforsker: Rosella P.M.G. Hermens, MD,PhD, Radboud University Medical Center
- Hovedetterforsker: Elizabeth M. Swisher, MD, PhD, University of Washington
- Hovedetterforsker: Karen H. Lu, MD, PhD, Moffitt Cancer Center & Research Institute
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Pennington KP, Pugh SL, Huh W, Walker JL, Jewell E, Havrilesky LJ, Carter J, Muller CY, Drapkin R, Lankes HA, Castellano T, Zamorano AS, Blank SV, Kachnic LA. Optimization of Timing for Risk-Reducing Salpingectomy and Oophorectomy. Obstet Gynecol. 2025 Jan 1;145(1):21-30. doi: 10.1097/AOG.0000000000005781. Epub 2024 Nov 7.
- Steenbeek MP, van Bommel MHD, intHout J, Peterson CB, Simons M, Roes KCB, Kets M, Norquist BM, Swisher EM, Hermens RPMG; TUBA-WISP II consortium; Lu KH, de Hullu JA. TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol. Int J Gynecol Cancer. 2023 Jun 5;33(6):982-987. doi: 10.1136/ijgc-2023-004377.
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Urogenitale sykdommer
- Kjønnssykdommer
- Sykdommer i det endokrine systemet
- Urogenitale neoplasmer
- Neoplasmer etter nettsted
- Neoplasmer
- Kvinnelige urogenitale sykdommer
- Kvinnelige urogenitale sykdommer og graviditetskomplikasjoner
- Kjønnssykdommer, kvinner
- Neoplasmer i endokrine kjertel
- Sykdommer i eggstokkene
- Adnexal sykdommer
- Genitale neoplasmer, kvinnelige
- Gonadal lidelser
- Neoplasmer i eggstokkene
Andre studie-ID-numre
- NL 70691.091.19
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .